HDAC9 and chronic myelogenous leukemia, BCR-ABL1 positive: Interestingly, the regulation of HDAC1 is of particular importance for the survival of K562 CML cells, and panobinostat (non-selective HDAC inhibitor) induced apoptosis in both imatinib-sensitive and -resistant K562 cells [62].